The Prevalence and Impacts of Nudix Hydrolase 15 (NUDT15) Gene Variants in Taiwanese Inflammatory Bowel Disease

Recruiting Observational Study
Inflammatory Bowel Diseases Neutropenia Nudt15 Deficiency
No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
1 – 25
Sex
Any
Study type
Observational
Participants needed
65 (estimated)
Sponsor
National Taiwan University Hospital · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The study will include participants who were diagnosed with inflammatory disease and followed up at National Taiwan University Children's Hospital. The investigators will check the NUDT15 gene test, if the participant agrees to do an additional blood test. The result of the gene test will be analyzed and compared with other clinical data.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Participants who are diagnosed with inflammatory bowel disease. Exclusion Criteria: * Participants who refused to have blood test for NUDT15 gene evaluation.
Contacts

Wei-Ting Chen, MD

+886-2-2312-3456

DBE98@tepch.gov.tw

CONTACT

Jia-Feng Wu, MD, PhD

+886-2-2312-3456

wjf@ntu.edu.tw

CONTACT